IMC Chicago’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.1K Buy
+45,600
New +$93.9K ﹤0.01% 5410
2025
Q1
Sell
-97,200
Closed -$229K 3432
2024
Q4
$229K Buy
97,200
+23,700
+32% +$416K ﹤0.01% 3062
2024
Q3
$2.16M Buy
73,500
+49,700
+209% +$1.14M ﹤0.01% 1614
2024
Q2
$294K Sell
23,800
-6,900
-22% -$145K ﹤0.01% 2484
2024
Q1
$623K Sell
30,700
-24,300
-44% -$560K ﹤0.01% 1949
2023
Q4
$1.24M Sell
55,000
-6,800
-11% -$144K ﹤0.01% 1364
2023
Q3
$1.03M Buy
61,800
+13,400
+28% +$266K ﹤0.01% 1214
2023
Q2
$1.19M Sell
48,400
-27,700
-36% -$667K ﹤0.01% 1013
2023
Q1
$1.84M Sell
76,100
-83,200
-52% -$2.31M ﹤0.01% 872
2022
Q4
$4.71M Sell
159,300
-283,400
-64% -$10.2M 0.01% 622
2022
Q3
$18.5M Buy
442,700
+392,500
+782% +$10.6M 0.02% 303
2022
Q2
$1.41M Sell
50,200
-79,200
-61% -$2M ﹤0.01% 763
2022
Q1
$4.81M Sell
129,400
-149,900
-54% -$6.35M ﹤0.01% 571
2021
Q4
$12.2M Buy
279,300
+25,900
+10% +$1.36M 0.01% 455
2021
Q3
$15.7M Buy
253,400
+237,900
+1,535% +$19.9M 0.02% 405
2021
Q2
$1.32M Buy
+15,500
New +$830K ﹤0.01% 854

Other funds holding FLNA

IMC Chicago's FLNA Position: Q4 2024 in Review

IMC Chicago sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 39,792 shares — an estimated $699K sold.

IMC Chicago first reported a position in FLNA in Q2 2021 and held it in 6 quarters. The position peaked at $1.84M in Q4 2022. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • IMC Chicago reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • IMC Chicago sold 39,792 Filana Therapeutics shares in Q4 2024, an estimated $699K.
  • IMC Chicago first reported a position in Filana Therapeutics in Q2 2021 and held it in 6 quarters.
  • IMC Chicago's Filana Therapeutics position peaked at $1.84M in Q4 2022.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on IMC Chicago's 13F filing for Q4 2024, filed 27 Jan 2025.